219 related articles for article (PubMed ID: 20855498)
21. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK.
Buza-Vidas N; Antonchuk J; Qian H; Månsson R; Luc S; Zandi S; Anderson K; Takaki S; Nygren JM; Jensen CT; Jacobsen SE
Genes Dev; 2006 Aug; 20(15):2018-23. PubMed ID: 16882979
[TBL] [Abstract][Full Text] [Related]
22. SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.
Kim KL; Seo S; Kim JT; Kim J; Kim W; Yeo Y; Sung JH; Park SG; Suh W
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2120-2131. PubMed ID: 31434494
[TBL] [Abstract][Full Text] [Related]
23. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
24. Reduced repression of cytokine signaling ameliorates age-induced decline in hematopoietic stem cell function.
Norddahl GL; Wahlestedt M; Gisler S; Sigvardsson M; Bryder D
Aging Cell; 2012 Dec; 11(6):1128-31. PubMed ID: 22809070
[TBL] [Abstract][Full Text] [Related]
25. A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal.
Zhang Z; Zhu P; Zhou Y; Sheng Y; Hong Y; Xiang D; Qian Z; Mosenson J; Wu WS
Leukemia; 2017 Feb; 31(2):403-413. PubMed ID: 27451973
[TBL] [Abstract][Full Text] [Related]
26. Stem cell factor is a potent endothelial permeability factor.
Kim JY; Choi JS; Song SH; Im JE; Kim JM; Kim K; Kwon S; Shin HK; Joo CK; Lee BH; Suh W
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1459-67. PubMed ID: 24790137
[TBL] [Abstract][Full Text] [Related]
27. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein.
Takaki S; Tezuka Y; Sauer K; Kubo C; Kwon SM; Armstead E; Nakao K; Katsuki M; Perlmutter RM; Takatsu K
J Immunol; 2003 Jan; 170(2):703-10. PubMed ID: 12517931
[TBL] [Abstract][Full Text] [Related]
28. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis.
Lee DY; Cho TJ; Kim JA; Lee HR; Yoo WJ; Chung CY; Choi IH
Bone; 2008 May; 42(5):932-41. PubMed ID: 18326482
[TBL] [Abstract][Full Text] [Related]
29. Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury.
Kamei N; Kwon SM; Alev C; Ishikawa M; Yokoyama A; Nakanishi K; Yamada K; Horii M; Nishimura H; Takaki S; Kawamoto A; Ii M; Akimaru H; Tanaka N; Nishikawa S; Ochi M; Asahara T
Stem Cells; 2010 Feb; 28(2):365-75. PubMed ID: 19859984
[TBL] [Abstract][Full Text] [Related]
30. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice.
Velazquez L; Cheng AM; Fleming HE; Furlonger C; Vesely S; Bernstein A; Paige CJ; Pawson T
J Exp Med; 2002 Jun; 195(12):1599-611. PubMed ID: 12070287
[TBL] [Abstract][Full Text] [Related]
31. Adaptor protein Lnk associates with Tyr(568) in c-Kit.
Gueller S; Gery S; Nowak V; Liu L; Serve H; Koeffler HP
Biochem J; 2008 Oct; 415(2):241-5. PubMed ID: 18588518
[TBL] [Abstract][Full Text] [Related]
32. LNK (SH2B3) inhibition expands healthy and Fanconi anemia human hematopoietic stem and progenitor cells.
Holdreith N; Lee G; Chandra V; Salinas CS; Nicholas P; Olson TS; Tong W
Blood Adv; 2022 Feb; 6(3):731-745. PubMed ID: 34844262
[TBL] [Abstract][Full Text] [Related]
33. Expression of the adaptor protein Lnk in leukemia cells.
Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
[TBL] [Abstract][Full Text] [Related]
34. The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.
Velazquez L
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):415-29. PubMed ID: 22990499
[TBL] [Abstract][Full Text] [Related]
35. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
36. Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.
Louria-Hayon I; Frelin C; Ruston J; Gish G; Jin J; Kofler MM; Lambert JP; Adissu HA; Milyavsky M; Herrington R; Minden MD; Dick JE; Gingras AC; Iscove NN; Pawson T
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20599-604. PubMed ID: 24297922
[TBL] [Abstract][Full Text] [Related]
37. Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.
Olivos DJ; Alvarez M; Cheng YH; Hooker RA; Ciovacco WA; Bethel M; McGough H; Yim C; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2017 Aug; 118(8):2231-2240. PubMed ID: 28067429
[TBL] [Abstract][Full Text] [Related]
38. Stem cell factor (SCF) protects osteoblasts from oxidative stress through activating c-Kit-Akt signaling.
Yang L; Wu Z; Yin G; Liu H; Guan X; Zhao X; Wang J; Zhu J
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):256-61. PubMed ID: 25449280
[TBL] [Abstract][Full Text] [Related]
39. p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche.
Chang KH; Sengupta A; Nayak RC; Duran A; Lee SJ; Pratt RG; Wellendorf AM; Hill SE; Watkins M; Gonzalez-Nieto D; Aronow BJ; Starczynowski DT; Civitelli R; Diaz-Meco MT; Moscat J; Cancelas JA
Cell Rep; 2014 Dec; 9(6):2084-97. PubMed ID: 25533346
[TBL] [Abstract][Full Text] [Related]
40. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling.
Devallière J; Charreau B
Biochem Pharmacol; 2011 Nov; 82(10):1391-402. PubMed ID: 21723852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]